ArticleOncology letters2026
Fever and leukemoid reaction in bladder cancer: A case report.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study presented and analyzed the clinical data of a patient who had bladder cancer complicated by a leukemoid reaction, aiming to discuss the diagnosis, treatment and underlying mechanism of leukemoid reactions in bladder cancer. The patient had a significant smoking history and underwent six transurethral resections of bladder tumors between August 2016 and October 2023. Pathological diagnosis deteriorated from low-grade papillary urothelial carcinoma (UC) to high-grade papillary urothelial carcinoma. The patient did not adhere to regular cystoscopy or routine follow-up cystoscopy and declined radical cystectomy. The most recent computed tomography scan revealed the following: i) Multiple tumors in the bladder; ii) invasion at the bilateral ureteral orifices; iii) dilation of the bilateral renal pelvis and ureters; and iv) multiple lymphadenopathies in the pelvis and along the right iliac artery. Following cystoscopy examination and urethral catheter placement, the patient's creatinine level gradually decreased; however, there was an increase in body temperature and white blood cell count. The patient was diagnosed with a leukemoid reaction secondary to bladder cancer. The patient refused a bone marrow biopsy and palliative care was administered. The patient passed away in October 2023. Cases of bladder cancer complicated by a leukemoid reaction are rarely reported clinically. Even after surgical resection, the prognosis remains poor. Monitoring granulocyte-colony stimulating factor (G-CSF) levels in blood can aid in predicting the condition of the patient's health. Blocking the G-CSF signaling pathway might serve as a future therapeutic target for bladder cancer complicated by a leukemoid reaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.